Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haffner

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Biorxiv : the Preprint Server for Biology|December 3, 2025
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
Nature Methods|June 22, 2026
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Genome Biology|December 15, 2020
Convergent network effects along the axis of gene expression during prostate cancer progressionKonstantina Charmpi, Tiannan Guo, Qing Zhong, et al.
Cell Reports|October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerPreston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|December 3, 2025
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
Nature Methods|June 22, 2026
3D pathology-guided microdissectionHuai-Ching Hsieh, Gan Gao, Qinghua Han, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Genome Biology|December 15, 2020
Convergent network effects along the axis of gene expression during prostate cancer progressionKonstantina Charmpi, Tiannan Guo, Qing Zhong, et al.
Cell Reports|October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerPreston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
Pageof 21